Remission Rates, Time to Remission, and Related Factors in Adolescents with Major Depressive Disorder

被引:0
作者
Topal, Zehra [1 ]
Ozturk, Yusuf [2 ]
Demir, Nuran [3 ]
Adiguzel, Oznur [4 ]
Karadag, Mehmet [1 ]
Tufan, Ali Evren [5 ]
机构
[1] Gaziantep Univ, Sahinbey Res & Practice Hosp, Dept Child & Adolescent Psychiat, Sch Med, Gaziantep, Turkey
[2] Abant Izzet Baysal Univ, Dept Child & Adolescent Psychiat, Fac Med, Bolu, Turkey
[3] Yildirim Bayezit Univ, Dept Child & Adolescent Psychiat, Ankara, Turkey
[4] Ordu Univ Training & Res Hosp, Dept Child & Adolescent Psychiat, Ordu, Turkey
[5] Acibadem Mehmet Ali Aydinlar Univ, Dept Child & Adolescent Psychiat, Istanbul, Turkey
来源
EUROPEAN JOURNAL OF THERAPEUTICS | 2021年 / 27卷 / 03期
关键词
Adolescent depression; treatment outcomes; remission; PLACEBO-CONTROLLED TRIAL; CHILDREN; FLUOXETINE; CHILDHOOD; SYMPTOMS; SCALE;
D O I
10.5152/eurjther.2021.20081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Major depressive disorder (MDD) is a common disorder in children and adolescents that can cause serious morbidity and mortality. Although response rates to treatment are high, less than half of the adolescents with MDD achieve remission. The present study aims to evaluate remission rates, time to remission, and the predictors of remission in adolescents with MDD. Methods: This study included 34 adolescents with MDD who were followed-up for a minimum period of 120days. The adolescents were assessed with the Clinic Global Impression Scale, Beck Depression Inventory, Young Mania Rating Scale, Child Mania Rating Scale, and Screen for Child Anxiety-Related Emotional Disorders at the baseline and at weeks 4, 8, and 12. Results: 67.6% of the adolescents had at least one comorbid diagnosis. The remission rate at week 12 was 735%. The mean time to remission was 72.0days. The female adolescents achieved a significantly higher remission rate than the males. Conclusion: The majority of adolescents achieved remission following acute treatment, and that the time to remission for the female adolescents was shorter compared with the males. Remission time does seem neither to be related to the number of medications prescribed nor to the number of comorbid diagnoses.
引用
收藏
页码:219 / 223
页数:5
相关论文
共 28 条
[21]   A comparison of cognitive-behavioral therapy, sertraline, and their combination for adolescent depression [J].
Melvin, Glenn A. ;
Tonge, Bruce J. ;
King, Neville J. ;
Heyne, David ;
Gordon, Michael S. ;
Klimkeit, Ester .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (10) :1151-1161
[22]   Child mania rating scale: Development, reliability, and validity [J].
Pavuluri, MN ;
Henry, DB ;
Devineni, B ;
Carbray, JA ;
Birmaher, B .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (05) :550-560
[23]   Report by the ACNP Task Force on response and remission in major depressive disorder [J].
Rush, A. John ;
Kraemer, Helena C. ;
Sackeim, Harold A. ;
Fava, Maurizio ;
Trivedi, Madhukar H. ;
Frank, Ellen ;
Ninan, Philip T. ;
Thase, Michael E. ;
Gelenberg, Alan J. ;
Kupfer, David J. ;
Regier, Darrel A. ;
Rosenbaum, Jerrold F. ;
Ray, Oakley ;
Schatzberg, Alan F. .
NEUROPSYCHOPHARMACOLOGY, 2006, 31 (09) :1841-1853
[24]   Trajectories of Symptom Change in the Treatment for Adolescents With Depression Study [J].
Scott, Kelli ;
Lewis, Cara C. ;
Marti, C. Nathan .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (03) :319-328
[25]  
Thase ME, 2003, J CLIN PSYCHIAT, V64, P3
[26]  
Topal Z., 2016, TURKIYE KLINIKLERI J, V2, P79
[27]   A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents [J].
Wagner, KD ;
Robb, AS ;
Findling, RL ;
Jin, JQ ;
Gutierrez, MM ;
Heydorn, WE .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (06) :1079-1083
[28]   Clinical characteristics of depressive symptoms in children and adolescents with major depressive disorder [J].
Yorbik, O ;
Birmaher, B ;
Axelson, D ;
Williamson, DE ;
Ryan, ND .
JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (12) :1654-1659